SCT Annual Meeting Presentations & Videos
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations.

Discover SCT's Scientific Knowledge-Bank

  261 Learning Opportunities Found

swap_vert Primary Presenter

swap_vert Presentation Information

swap_vert Media Type(s)

Richard Stephens
2016 (Montreal) Annual Meeting
Founders Lecture
Patients as Partners in Cancer Research
 Watch Video
LEAP Trial team
2016 (Montreal) Annual Meeting
Trial of the Year Award
Learning Early About Peanut Allergy (LEAP)
 Watch Video
Wendy Parulekar
2016 (Montreal) Annual Meeting
Presidential Welcome
 Watch Video
Denis Lacombe
2016 (Montreal) Annual Meeting
Curtis Meinert Lecture
EOTRC (European Organisation for Research and Treatment of Cancer)
 Watch Video
Mark Espeland
2016 (Montreal) Annual Meeting
Fellows Presentation
Presentation of the Class of 2016 Fellows
 Watch Video
Professor Paula Williamson
2016 (Montreal) Annual Meeting
Session Proposal
"Improving health by improving trials" – the UK Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR): a nation-wide network to develop capacity and optimise trial design and conduct
Session Details
Professor Barney Reeves
2016 (Montreal) Annual Meeting
Session Proposal
“It’s always too early until suddenly it’s too late”: designing surgical RCTs relevant to patients, staff and changing technologies
Session Details
Haitao Pan
2016 (Montreal) Annual Meeting
Contributed Session
A Bayesian Adaptive Group Sequential Design for Biosimilars with Historical Data
Session Details
Catherine Oldenburg
2016 (Montreal) Annual Meeting
Contributed Session
A CASE FOR CACE: THE COMPLIER AVERAGE CAUSAL EFFECT IN RANDOMIZED CONTROLLED TRIALS
Session Details
Michael Palmer
2016 (Montreal) Annual Meeting
Contributed Session
A Classification Framework For Root Causes Of Missing Data With Patient Reported Outcomes In Prospective Studies
Session Details
Geetha Beauchamp
2016 (Montreal) Annual Meeting
Contributed Session
A CLUSTER RANDOMIZED ANALYSIS OF SITE-LEVEL HIV SURVEILLANCE DATA IN HPTN 065 (TLC-PLUS) STUDY
Session Details
Paula Darby Lipman
2016 (Montreal) Annual Meeting
Contributed Session
A COLLABORATIVE STRATEGY TO CONDUCT AND LEARN FROM HIGH IMPACT PRAGMATIC TRIALS
Session Details
Nathaniel O'Connell
2016 (Montreal) Annual Meeting
Contributed Session
A latent variable approach to elicit continuous toxicity scores and severity weights for multiple toxicities in cancer clinical trials
Session Details
Mohamed-Amine Bayar
2016 (Montreal) Annual Meeting
Contributed Session
A long-term horizon simulation study to guide time-to-event RCTs with interim analyses in rare diseases
Session Details
Eric Tustison
2016 (Montreal) Annual Meeting
Contributed Session
A Nested Query Method for Efficient Enforcement of Timely Data Entry for Scheduled Outcomes
Session Details
Laura Collett
2016 (Montreal) Annual Meeting
Contributed Session
A NOVEL METHOD FOR ADJUSTING SURVIVAL ANALYSES TO REMOVE THE CONFOUNDING EFFECTS OF SUBSEQUENT THERAPY (CASCADE)
Session Details
David M. Murray
2016 (Montreal) Annual Meeting
Session Proposal
A practical overview of missing data issues in cluster-randomized designs for pragmatic trials
Session Details
Martin Tickle
2016 (Montreal) Annual Meeting
Contributed Session
A randomised control trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services (Northern Ireland Caries Prevention In Practice Trial - NIC-PIP trial)
Session Details
Alan Girling
2016 (Montreal) Annual Meeting
Contributed Session
A restricted randomisation scheme for stepped-wedge studies with a cluster-level covariate
Session Details
Cole Wayant
2016 (Montreal) Annual Meeting
Contributed Session
A review of outcomes presented in published and unpublished studies of pediatric acute lymphoblastic leukemia: Toward the development of a core outcome set.
Session Details
Yaoyao Xu
2016 (Montreal) Annual Meeting
Contributed Session
A Seamless Phase 2/3 Design Based on Continuous Outcome
Session Details
Soe Soe Thwin
2016 (Montreal) Annual Meeting
Contributed Session
A simple approach to assess enrollment prediction in clinical trials
Session Details
Allan Walker
2016 (Montreal) Annual Meeting
Contributed Session
A smarter stock re-supply mechanism for multi-centre drug trials where participants are prescribed drugs at multiple visits - an example from the MS-SMART trial
Session Details
Matthew Sims
2016 (Montreal) Annual Meeting
Contributed Session
A SYTEMATIC REVIEW OF CORE DOMAIN AND OUTCOME MEASUREMENT FOR SHOULDER ARTHROPLASTY TRIALS
Session Details
Kevin Wilson
2016 (Montreal) Annual Meeting
Contributed Session
A Tool to Generate and Validate Permuted-Block Randomization Tables
Session Details
Graham Wheeler
2016 (Montreal) Annual Meeting
Contributed Session
A toxicity-dependent feasibility bound for the Escalation with Overdose Control approach in phase I cancer trials
Session Details
Meghan Engbretson
2016 (Montreal) Annual Meeting
Contributed Session
ACADEMIC COOPERATIVE GROUP IMPLEMENTATION OF THE INITIATIVE TO STREAMLINE CLINICAL TRIALS
Session Details
Ileana Baldi
2016 (Montreal) Annual Meeting
Contributed Session
Accrual monitoring in cardiology research
Session Details
Neil Corrigan
2016 (Montreal) Annual Meeting
Contributed Session
Adjusting for learning effects in a surgical RCT
Session Details
DONALD TAVES
2016 (Montreal) Annual Meeting
Contributed Session
Advances in the Minimization vs. Randomization Debate
Session Details
Avie-Lee Tillotson
2016 (Montreal) Annual Meeting
Contributed Session
Adverse event coding in early phase trials
Session Details
Yiyi Chen
2016 (Montreal) Annual Meeting
Contributed Session
An Adaptive Bayesian Sequential Design Implemented Through an Interactive Software for Onsite Treatment Assignment
Session Details
Gennaro De Crescenzo
2016 (Montreal) Annual Meeting
Contributed Session
An efficient and economic solution for a clinical trial - Registry-based Randomized Clinical Trial (RRCT)
Session Details
Austin Horn
2016 (Montreal) Annual Meeting
Contributed Session
An ethical analysis of the SUPPORT study: Addressing challenges posed by a randomized controlled trial comparing standard treatments used in medical practice.
Session Details
Rebecca Simpson
2016 (Montreal) Annual Meeting
Contributed Session
AN INVESTIGATION OF THE FACTORS WHICH INFLUENCE CHILDREN WITH ASTHMA HAVING UNSCHEDULED MEDICAL CONTACTS AROUND THE START OF THE NEW SCHOOL YEAR IN ENGLAND AND WALES
Session Details
Corrado Lanera
2016 (Montreal) Annual Meeting
Contributed Session
ANALYSIS OF FREE TEXT ON ELECTRONIC MEDICAL REPORTS USING SEMI-SUPERVISED MACHINE LEARNING TECHNIQUES: A COMPARATIVE CASE-STUDY ON VARICELLA
Session Details
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
ANALYSIS OF THE CROSS-SECTIOTIONAL STEPPED WEDGE CLUSTER RANDOMSIED TRIAL
Session Details
Brittney Bailey
2016 (Montreal) Annual Meeting
Contributed Session
Analyzing Binary Outcome Data from an Individually Randomized Group Treatment Trial
Session Details
Samantha Hinsley
2016 (Montreal) Annual Meeting
Contributed Session
APPLICATION OF A BAYESIAN APPROACH TO TREATMENT SELECTION IN A RARE DISEASE SUB-POPULATION
Session Details
James Rochon
2016 (Montreal) Annual Meeting
Contributed Session
APPLICATION OF THE MARGINAL STRUCTURAL MODEL TO ACCOUNT FOR SUBOPTIMAL ADHERENCE IN A RANDOMIZED CONTROLLED TRIAL
Session Details
Gillian Gresham
2016 (Montreal) Annual Meeting
Contributed Session
Applications of wearable activity monitors in randomized clinical trials (RCT) in chronic disease populations: A review of the literature
Session Details
Ines Rombach
2016 (Montreal) Annual Meeting
Contributed Session
APPLYING MULTIPLE IMPUTATION TO MULTI-ITEM PATIENT REPORTED OUTCOME MEASURES: ADVANTAGES AND DISADVANTAGES OF IMPUTING AT THE ITEM, SUB-SCALE OR SCORE LEVEL
Session Details
Raymond Kraker
2016 (Montreal) Annual Meeting
Contributed Session
ARE LESS ACTIVE SITES MORE LIKELY TO DEVIATE FROM STUDY PROTOCOL AND PROCEDURES?
Session Details
Susan Halabi
2016 (Montreal) Annual Meeting
Contributed Session
Are Prognostic Models Valuable Tools in Guiding Treatment Decisions?
Session Details
Susan Halabi
2016 (Montreal) Annual Meeting
Session Proposal
Are Prognostic Models Valuable Tools in Guiding Treatment Decisions?
Session Details
Joanna Crocker
2016 (Montreal) Annual Meeting
Contributed Session
Assessing the impact of patient and public involvement on enrolment and retention in clinical trials: a systematic review
Session Details
Wenle Zhao
2016 (Montreal) Annual Meeting
Contributed Session
ASYMPTOTIC MAXIMAL PROCEDURE FOR SUBJECT RANDOMIZATION
Session Details
Sam T Mathew
2016 (Montreal) Annual Meeting
Session Proposal
Authorship of clinical trial publications. Is there a way to quantify the involvement and provide appropriate credit to the contributors?
Session Details
Hope Bryan
2016 (Montreal) Annual Meeting
Contributed Session
AUTOMATING THE EVENT REVIEW AND ADJUDICATION PROCESS FOR LARGE LONGITUDINAL STUDIES
Session Details
Robert Lew
2016 (Montreal) Annual Meeting
Contributed Session
Balancing site characteristics for stepped wedge designs
Session Details
Catherine Lowe
2016 (Montreal) Annual Meeting
Contributed Session
BEYOND THE PARTICIPANT INFORMATION SHEET: UTILISING PATIENT AND PUBLIC INVOLVEMENT TO IMPROVE PARTICIPANT INFORMATION
Session Details
Sabine Landau
2016 (Montreal) Annual Meeting
Contributed Session
Beyond total treatment effects in RCTs: Baseline measurement of intermediate outcomes needed to avoid confounding in mediation investigations
Session Details
Aurore Giljean
2016 (Montreal) Annual Meeting
Contributed Session
BIOMEDE Trial: a European randomized Phase 2 trial based on biomarkers evaluating new drugs in Diffuse Intrinsic Pontine Glioma (DIPG).
Session Details
Nicola Soriani
2016 (Montreal) Annual Meeting
Contributed Session
BIOSTAPP: AN INTEGRATED REPORTING AND MONITORING SYSTEM FOR CLINICAL STUDIES USING OPEN SOURCE SYSTEM
Session Details
Robert Califf
2016 (Montreal) Annual Meeting
Session Proposal
Building the Clinical Trials Enterprise of the Future
Session Details
Martina McMenamin
2016 (Montreal) Annual Meeting
Contributed Session
CAUSAL MODELLING IN TRIALS WITH SMALL SAMPLE SIZES
Session Details
Catherine Dillon
2016 (Montreal) Annual Meeting
Session Proposal
Central IRBs: Implementation, Effectiveness, and Optimization
Session Details
Catherine Dillon
2016 (Montreal) Annual Meeting
Session Proposal
Challenges and Solutions to the Coordination and Conduct of an Emergency Treatment Trial
Session Details
Caitlyn Ellerbe
2016 (Montreal) Annual Meeting
Session Proposal
Challenges of Implementing an Adaptive Design in an Academic Network Setting
Session Details
Dave Shade
2016 (Montreal) Annual Meeting
Contributed Session
CHARACTERIZATION OF DOUBLE-DATA-ENTRY IN DATA ENTRY SYSTEMS EMPLOYING MODERN INTERFACE ELEMENTS.
Session Details
Erika Cullingford
2016 (Montreal) Annual Meeting
Contributed Session
CLINICAL PROTOCOL DISSECTION: BEST PRACTICES TO REVIEWING A PROTOCOL THROUGH DIFFERENT ROLES AND STAGES FROM THE PERSPECTIVE OF A MULTI-PROJECT CRO
Session Details
Faye Williamson
2016 (Montreal) Annual Meeting
Contributed Session
Clinical Trial Design for Rare Diseases using Bayesian Bandit Models
Session Details
Jeannette Lee
2016 (Montreal) Annual Meeting
Contributed Session
Clinical Trial Participation Among HIV-infected Persons with Cancer
Session Details
Marie-Claude Boily
2016 (Montreal) Annual Meeting
Session Proposal
Clinical trial simulations: the when, where and what
Session Details
Valerie Durkalski
2016 (Montreal) Annual Meeting
Session Proposal
Collaborating with Patient Advocacy Groups at the Design Stage of your Clinical Trial, and Why is it so Important
Session Details
Tracey Davidson
2016 (Montreal) Annual Meeting
Contributed Session
Comparing the feasibility and acceptability of collecting patient reported outcomes using text message and paper diary
Session Details
Ayodele Odutayo
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of Clinical Trial Protocols and Clinical Trial Registry Entries: A Cross-sectional Study
Session Details
Nicole Solomon
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of Regression Imputation Methods for the Analysis of Time-to-event Endpoints Subject to Censoring
Session Details
Kaleab Abebe
2016 (Montreal) Annual Meeting
Contributed Session
Comparison of two Screening Strategies for Gestational Diabetes (GDM2) Trial: Design and Rationale
Session Details
Ashley Hogan
2016 (Montreal) Annual Meeting
Contributed Session
CONSIDERATIONS AND CHALLENGES FOR TRANSITION TO MOBILE ELECTRONIC PATIENT REPORTED OUTCOMES (ePRO) IN A LONG-TERM TRIAL WITH AN AGING AND DIVERSE POPULATION
Session Details
Donna Reidlinger
2016 (Montreal) Annual Meeting
Contributed Session
Consumers and the community as true partners in research
Session Details
Julian Wolfson, PhD
2016 (Montreal) Annual Meeting
Session Proposal
Courage, controversy, and clinical trials: Lessons from the Ebola epidemic
Session Details
Mary Putt, PhD, ScD
2016 (Montreal) Annual Meeting
Session Proposal
Crossover Trials: New Perspectives and Practical Implications for an Efficient Design
Session Details
Jane Perlmutter
2016 (Montreal) Annual Meeting
Contributed Session
CTTI’s Recommendations for Improving Informed Consent
Session Details
Shaun Treweek
2016 (Montreal) Annual Meeting
Session Proposal
Data and Biorepositories: Enhancing Collaborative Science
Session Details
Leonard Friedman
2016 (Montreal) Annual Meeting
Contributed Session
Data quality management in NeuroBANK; a clinical research data aggregation platform
Session Details
Doussau Adelaide
2016 (Montreal) Annual Meeting
Contributed Session
DECIPHERING ASSUMPTIONS ABOUT STEPPED WEDGE DESIGNS: THE CASE OF EBOLA VACCINE RESEARCH
Session Details
Richard Emsley
2016 (Montreal) Annual Meeting
Contributed Session
Design issues in trials of complex and digital interventions
Session Details
Dr Gillian Lancaster
2016 (Montreal) Annual Meeting
Session Proposal
Design, conduct and reporting of pilot and feasibility studies carried out in a health care setting in preparation for a randomised controlled trial testing the effectiveness of a complex intervention
Session Details
Caroline Brard
2016 (Montreal) Annual Meeting
Contributed Session
Designing a Bayesian randomized controlled trial in osteosarcoma: how to incorporate historical data?
Session Details
Dikla Shmueli-Blumberg
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPING A COMPREHENSIVE AND EFFECTIVE PROCESS FOR CLOSING OUT A STUDY: STRATEGIES FROM CLOSING OUT MULTI-SITE SUBSTANCE USE TREATMENT CLINICAL TRIALS
Session Details
Anne Hoehn
2016 (Montreal) Annual Meeting
Contributed Session
Developing a Data Management Plan for Electronic Medical Records Abstraction within Clinical Trials: A Report from NIDA CTN Studies
Session Details
Nisha Grover
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPING A MOBILE-BASED ePRO SYSTEM
Session Details
Joanna Crocker
2016 (Montreal) Annual Meeting
Contributed Session
Developing a Patient and public Involvement intervention to enhance Recruitment and Retention In UK Surgical Trials (PIRRIST)
Session Details
Yong Ma; Junshan Qiu
2016 (Montreal) Annual Meeting
Session Proposal
Development in Evaluating Cardiovascular Risk: Pre- and Post-marketing
Session Details
Magda Monreal
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A COLLABORATIVE APPROACH TO ACCRUAL OF ADOLESCENTS AND YOUNG ADULTS WITH CANCER TO CLINICAL TRIALS IN CANADA: A JOINT REPORT FROM THE PEDIATRIC C17 COUNCIL AND THE ADULT CANADIAN CANCER TRIALS GROUP.
Session Details
Zachary Sanchez
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A CORE OUTCOME SET FOR HYPEREMESIS GRAVIDARUM
Session Details
Gregory Aran
2016 (Montreal) Annual Meeting
Contributed Session
DEVELOPMENT OF A CORE OUTCOME SET FOR PEDIATRIC POSTOPERATIVE PAIN
Session Details
Dave Shade
2016 (Montreal) Annual Meeting
Contributed Session
DISTRIBUTION OF ITEM TYPES USED IN CASE REPORT FORMS IMPLEMENTED IN MODERN DATA MANAGEMENT SYSTEMS.
Session Details
Shaun Treweek
2016 (Montreal) Annual Meeting
Contributed Session
Do pragmatic trials trade-off internal validity for external validity?
Session Details
Michael Grayling
2016 (Montreal) Annual Meeting
Contributed Session
Do single-arm trials have a role in drug development plans incorporating randomised trials?
Session Details
Nicole C. Close, PhD
2016 (Montreal) Annual Meeting
Session Proposal
Don't Be Afraid: Risk Based Monitoring at a Deconstructed Level for Implementation
Session Details
Erin Gabriel
2016 (Montreal) Annual Meeting
Contributed Session
Early Phase Transmission Blocking Vaccine Trials: Evaluation without Validated Surrogates
Session Details
Emily V. Dressler
2016 (Montreal) Annual Meeting
Session Proposal
Early-Phase Designs for Contemporary Dose-Finding Problems in Oncology
Session Details
Cynthia L Green & Borje Darpo
2016 (Montreal) Annual Meeting
Session Proposal
ECG Assessment in Early Clinical Trials
Session Details
Aenne Glass
2016 (Montreal) Annual Meeting
Contributed Session
EFFECT OF 10 DIFFERENT POLYMORPHISMS ON PREOPERATIVE VOLUMETRIC CHARACTERISTICS OF GLIOBLASTOMA MULTIFORME - RESULTS OF A PILOT STUDY
Session Details
Kristen Cunanan
2016 (Montreal) Annual Meeting
Contributed Session
Efficient Basket Trial Designs
Session Details
Abigail Shoben
2016 (Montreal) Annual Meeting
Contributed Session
Efficient designs for comparing control, treatment, and treatment plus in randomized trials
Session Details
Steven A. Julious
2016 (Montreal) Annual Meeting
Session Proposal
Efficient study designs in clinical research
Session Details
J Athene Lane
2016 (Montreal) Annual Meeting
Contributed Session
Enhancing patient and public involvement in trial oversight committees through qualitative research with eight large trials facing challenges
Session Details
Dr. Michael C Sachs
2016 (Montreal) Annual Meeting
Session Proposal
Episodic, rare and hard to measure outcomes in infectious diseases: challenges to clinical trial design
Session Details
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
EQUIPOISE IN ACTION: AN INVESTIGATION ACROSS SIX PRAGMATIC RANDOMIZED CONTROLLED TRIALS
Session Details
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
Establishing an upper bound on the optimal cluster size in cluster randomised trials with a limited number of clusters
Session Details
Andrew Forbes
2016 (Montreal) Annual Meeting
Contributed Session
Estimation in multiple period cluster randomized trials with non-uniform correlation structure
Session Details
Dean Fergusson
2016 (Montreal) Annual Meeting
Session Proposal
Ethical challenges in pragmatic comparative effectiveness trials
Session Details
Dean Fergusson
2016 (Montreal) Annual Meeting
Session Proposal
Ethical challenges in pragmatic comparative effectiveness trials
Session Details
Dean Fergusson
2016 (Montreal) Annual Meeting
Session Proposal
Ethical challenges in pragmatic comparative effectiveness trials
Session Details
Ken Cheung
2016 (Montreal) Annual Meeting
Session Proposal
Evaluating Precision Medicine in Clinical Trials
Session Details
Andisheh Bakhshi
2016 (Montreal) Annual Meeting
Contributed Session
EVALUATION OF THE WORKING HEALTH SERVICE SCOTLAND
Session Details
J. Michael Dean
2016 (Montreal) Annual Meeting
Session Proposal
Evolution and Function of Clinical Research Networks: What drives success?
Session Details
Marinella Temprosa
2016 (Montreal) Annual Meeting
Session Proposal
Expanding Your Reach: Innovations and opportunities for remote participant visits to boost retention and enrollment in research studies
Session Details
Thomas Jaki
2016 (Montreal) Annual Meeting
Contributed Session
Factorial versus multi-arm multi-stage designs in clinical trials
Session Details
Amy Xia
2016 (Montreal) Annual Meeting
Session Proposal
FDA IND Reporting Final Rule Compels a New Dialog among the DMC, Sponsor and FDA
Session Details
Jennifer Mischke
2016 (Montreal) Annual Meeting
Contributed Session
FDA Pre-Submission Program Overview and How to Effectively use the Program to Move a Device to the US Market
Session Details
Samantha Hinsley
2016 (Montreal) Annual Meeting
Contributed Session
FUTILITY ANALYSIS CONSIDERATIONS FOR A PHASE II TRIAL WITH SHORT TERM NON-INFERIORITY AND LONG TERM SUPERIORITY CO-PRIMARY ENDPOINTS
Session Details
Jose-Miguel Yamal
2016 (Montreal) Annual Meeting
Contributed Session
Futility Trials Revisited: Do They Still Have a Place in Clinical Trial Research?
Session Details
Lee McDaniel
2016 (Montreal) Annual Meeting
Contributed Session
Generating survival times to simulate additive hazards models
Session Details
Toshimitsu Hamasaki
2016 (Montreal) Annual Meeting
Contributed Session
Group-sequential three-arm noninferiority clinical trial designs
Session Details
Prof Jonathan Cook
2016 (Montreal) Annual Meeting
Session Proposal
Guidance on specifying the target difference (“effect size”) for a RCT
Session Details
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
HOW PRE-TRIAL RESEARCH CAN TRANSFORM PRE-SPECIFIED RANDOMISED CONTROLLED TRIAL DESIGN: A CASE STUDY AND IMPLICATIONS FOR FUTURE PRACTICE
Session Details
David Beard
2016 (Montreal) Annual Meeting
Contributed Session
IMBALANCE IN RECRUITMENT BETWEEN SITES IN SURGICAL TRIALS: HOW PROBLEMATIC?
Session Details
Jonathan Cook
2016 (Montreal) Annual Meeting
Contributed Session
IMPACT OF TIMING OF FOLLOW-UP UPON OUTCOME IN A SURGICAL TRIAL
Session Details
Jennifer Gassman
2016 (Montreal) Annual Meeting
Contributed Session
Implementation of a three-stage recruitment tracking system in the Blood Pressure in Hemodialysis Pilot (BID) RCT comparing blood pressure level treatment arms
Session Details
Carolyn Wilson
2016 (Montreal) Annual Meeting
Contributed Session
Implementation of a web-based screen failure log with real-time data collection and assessment facilitated timely modification of eligibility criteria in an adjuvant lung cancer immunotherapy trial
Session Details
Wenle Zhao
2016 (Montreal) Annual Meeting
Contributed Session
IMPLEMENTATION OF BETTER AND SIMPLE ALTERNATIVES TO PERMUTED BLOCK DESIGN
Session Details
Rebecca Lewis
2016 (Montreal) Annual Meeting
Contributed Session
Implementing Electronic Data Capture (EDC) – Lessons Learnt
Session Details
Thomas Jemielita
2016 (Montreal) Annual Meeting
Contributed Session
Improved Power in Crossover Designs through Linear Combinations of Baselines
Session Details
Akshata Ashokkumar
2016 (Montreal) Annual Meeting
Contributed Session
IMPROVING CLINICAL TRIAL EFFICIENCY: USE OF CENTRAL IRB AND MASTER TRIAL AGREEMENTS
Session Details
Anne Duncan
2016 (Montreal) Annual Meeting
Contributed Session
Improving trial questionnaire response rates using behaviour change theory.
Session Details
Peiyao Cheng
2016 (Montreal) Annual Meeting
Contributed Session
INCREASE THE PRECISION OF EFFECT SIZE ESTIMATE IN TIME TO EVENT DATA WITH INTERVAL CENSORING USING UNBALANCED DESIGN
Session Details
Robert Lindblad, MD
2016 (Montreal) Annual Meeting
Session Proposal
Initiating a Clinical Trial in an Epidemic Hot Zone; The Sierra Leone Ebola Experience
Session Details
Haitao Pan
2016 (Montreal) Annual Meeting
Session Proposal
Innovative Trial Designs for Precision Medicine
Session Details
Judy Needham
2016 (Montreal) Annual Meeting
Contributed Session
Integrating Patient / Public Involvement in the NCIC Clinical Trials Group
Session Details
Chris Cook
2016 (Montreal) Annual Meeting
Contributed Session
INTEGRATING TRADITIONAL ELECTRONIC DATA CAPTURE (EDC) WITH NEW SYSTEMS
Session Details
Victoria Borg Debono
2016 (Montreal) Annual Meeting
Contributed Session
INTERIM DATA SHARING; WHAT INTERIM RESULTS OR INFORMATION SHOULD OR SHOULDN'T BE SHARED DURING THE INTERIM OF A RANDOMIZED CONTROLLED TRIAL WITH THOSE RESPONSIBLE FOR THE CONDUCT OF THE TRIAL?
Session Details
Fangxin Hong
2016 (Montreal) Annual Meeting
Session Proposal
Interim monitoring for clinical trials: then and now
Session Details
Koko Asakura
2016 (Montreal) Annual Meeting
Contributed Session
Interim monitoring of clinical trials with co-primary endpoints using predicted intervals
Session Details
Neal Oden
2016 (Montreal) Annual Meeting
Contributed Session
Interim Monitoring of Non-inferiority Trials
Session Details
Norma Diaz-Mayoral
2016 (Montreal) Annual Meeting
Contributed Session
INVENTORY MANAGEMENT: UTILIZATION OF THE BSI SYSTEM TO INTEGRATE SPECIMEN-RELATED DATA
Session Details
Andrew Cook
2016 (Montreal) Annual Meeting
Contributed Session
Involving Clinical Experts in Prioritising Topics for Pragmatic Trials: A Factorial Randomised Controlled Trial
Session Details
Paul Brocklehurst
2016 (Montreal) Annual Meeting
Contributed Session
It is not all about effectiveness. The use of efficiency measures in evaluative designs.
Session Details
Todd MacKenzie
2016 (Montreal) Annual Meeting
Session Proposal
Joint modeling in clinical trials
Session Details
Julie Croft
2016 (Montreal) Annual Meeting
Contributed Session
Key Trial & Data Management Considerations for Planning Surgical Trials
Session Details
Annabelle South (TBC)
2016 (Montreal) Annual Meeting
Session Proposal
Knowledge translation for clinical trials: experiences from trials in Canada, the UK and Africa
Session Details
Marina Djurfeldt
2016 (Montreal) Annual Meeting
Contributed Session
LAUNCHING THE CANADIAN CANCER TRIALS GROUP SITE TRAINING INITIATIVE
Session Details
Lauren Yesko
2016 (Montreal) Annual Meeting
Contributed Session
Lessons Learned In Collecting Participant Reported Outcome Data via Web-Based Data Systems
Session Details
Ruiqi Zhang
2016 (Montreal) Annual Meeting
Contributed Session
Long term follow-up in randomised trials with delayed intervention for the control group
Session Details
Brenda Kurland
2016 (Montreal) Annual Meeting
Session Proposal
Low Dose Computed Tomography (LDCT) screening for lung cancer: Opportunities for refinement using quantitative imaging biomarkers
Session Details
Rebecca Neiberg
2016 (Montreal) Annual Meeting
Contributed Session
MANAGING DATA QUALITY OF PARTICIPANT WEIGHTS UPLOADED FROM SMART SCALES: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL – EXTENSION PHASE
Session Details
Julian Wolfson
2016 (Montreal) Annual Meeting
Contributed Session
Matching-based sensitivity analysis for assessing mediation in randomized trials
Session Details
Annabelle South
2016 (Montreal) Annual Meeting
Contributed Session
Measuring the impact of clinical trials: developing and applying a set of impact metrics
Session Details
Jeannette Lee
2016 (Montreal) Annual Meeting
Contributed Session
MEDICATION ADHERENCE IN A STUDY TO PREVENT VAGINAL INFECTIONS
Session Details
Matthew Sims
2016 (Montreal) Annual Meeting
Contributed Session
METHODLOGICAL QUALITY AND RISK OF BIAS ASSESSMENTS IN ORTHOPEDIC SURGERY SYSTEMATIC REVIEWS
Session Details
Leila Rooshenas
2016 (Montreal) Annual Meeting
Contributed Session
METHODS FOR SELECTING HEALTH CONCEPTS AND DOMAINS FOR THE DEVELOPMENT OF PATIENT REPORTED OUTCOME MEASURES (PROMS): A CASE STUDY
Session Details
Patricia Feeney
2016 (Montreal) Annual Meeting
Contributed Session
Methods to minimize bias during the analysis of open-label, randomized controlled trials
Session Details
Tolulope Sajobi
2016 (Montreal) Annual Meeting
Contributed Session
Minimal Sufficient Balance Randomization for Endovascular Stroke Trials: Results from the ESCAPE trial
Session Details
Marion Campbell
2016 (Montreal) Annual Meeting
Contributed Session
Missing data matter: should trials routinely report their Fragility Index?
Session Details
Karla Hemming
2016 (Montreal) Annual Meeting
Contributed Session
MODELLING DIFFERENTIAL CLUSTERING AND TREATMENT EFFECT HETEROGENEITY IN PARALLEL AND STEPPED WEDGE CLUSTER RANDOMISED TRIALS
Session Details
Annabelle South
2016 (Montreal) Annual Meeting
Contributed Session
Models and impact of patient and public involvement in studies carried out by the MRC Clinical Trials Unit at UCL: Findings from 10 case studies
Session Details
Anne Hoehn
2016 (Montreal) Annual Meeting
Contributed Session
Monitoring Medication Adherence Using a Mobicontrol Application: A Case Study
Session Details
Suzanne Breeman
2016 (Montreal) Annual Meeting
Contributed Session
MULTI-ARM RANDOMISED CONTROLLED TRIALS: A TRIAL MANAGERS PERSPECTIVE
Session Details
Claire Cochran
2016 (Montreal) Annual Meeting
Contributed Session
Negotiating hurdles, providing solutions to problems; Sharing the Challenges and lessons of managing a seven year International RCT
Session Details
Rick Chappell
2016 (Montreal) Annual Meeting
Contributed Session
Null Hypothesis Scales in Non-Inferiority Trials
Session Details
Catherine Klersy
2016 (Montreal) Annual Meeting
Contributed Session
One size does not fit all: adherence to STROBE guidelines in sample size calculations from the perspective of an Ethical Committee
Session Details
Andrew Forbes
2016 (Montreal) Annual Meeting
Contributed Session
Optimal allocation in stepped wedge designs
Session Details
Rachael Williams
2016 (Montreal) Annual Meeting
Contributed Session
Optimising the drug development pathway and life cycle management through the integration of observational and interventional data and expertise
Session Details
Bray Patrick-Lake
2016 (Montreal) Annual Meeting
Session Proposal
Overcoming Barriers to Effective Research Partnerships with Patient Groups
Session Details
William Meurer, MD, MS
2016 (Montreal) Annual Meeting
Session Proposal
Partnering biostatisticians and clinicians to train the next generation of neurological clinical trialists: the National Institutes of Neurological Disorders and Stroke Clinical Trials Methodology Course (NINDS-CTMC)
Session Details
Gail McDonald
2016 (Montreal) Annual Meeting
Contributed Session
Patient Retention in Clinical Trials – The Canadian Cancer Trials Group (CCTG) Group Experience with Withdrawal of Consent and Lost to Follow Up
Session Details
Agnieshka Baumritter
2016 (Montreal) Annual Meeting
Contributed Session
Pilot Study of a Tiered Approach to ROP Screening (TARP) using a Weight Gain Predictive Model and a Telemedicine System
Session Details
Janet Holbrook
2016 (Montreal) Annual Meeting
Contributed Session
PLACEBOS ARE MORE EFFECTIVE IN WOMEN THAN MEN WITH ASTHMA
Session Details
Adrian Hernandez
2016 (Montreal) Annual Meeting
Session Proposal
Planning for the Future – Expanding Opportunities for Pragmatic Trials
Session Details
Hongsheng Wu
2016 (Montreal) Annual Meeting
Contributed Session
Power Calculation for stepped wedge designs with pre-post evaluations
Session Details
Shun Fu Lee
2016 (Montreal) Annual Meeting
Contributed Session
Power of the adjusted Q statistic for the meta-analysis of cluster randomization trials.
Session Details
Robert Lindblad, MD
2016 (Montreal) Annual Meeting
Session Proposal
Practical Experiences facilitating the use of “BIG” Health Care Clinical Data to Conduct Clinical Research
Session Details
Chad Winch
2016 (Montreal) Annual Meeting
Contributed Session
PRACTICAL IMPLEMENTATION OF AN ADAPTIVE CLINICAL TRIAL DESIGN IN A MULTI-STAGE RANDOMIZED PHASE II STUDY OF NOVEL COMBINATION THERAPY FOR THE TREATMENT OF RELAPSED AND REFRACTORY AGGRESSIVE B-CELL LYMPHOMA: CANADIAN CANCER TRIALS GROUP LY.17
Session Details
Scott Evans
2016 (Montreal) Annual Meeting
Session Proposal
Pragmatic Trials
Session Details
Nicola Soriani
2016 (Montreal) Annual Meeting
Contributed Session
PREDICTING OUTCOMES IN A CLINICAL TRIAL: A SUPER LEARNER APPROACH
Session Details
TINGTING LI
2016 (Montreal) Annual Meeting
Contributed Session
Presenting Interim Clinical Trial Data for Decision Makers with Diverse Backgrounds
Session Details
Bray Patrick-Lake
2016 (Montreal) Annual Meeting
Session Proposal
Proactively Addressing Enrollment Challenges – CTTI’s Recommendations for Improving Recruitment Planning and Informed Consent
Session Details
Nicola Greenlaw
2016 (Montreal) Annual Meeting
Contributed Session
Problems, solutions and challenges using routinely collected prescription dispensing data in a randomized controlled trial setting
Session Details
Lynda Ugwu
2016 (Montreal) Annual Meeting
Session Proposal
Prospective Individual Participant Data Meta-Analysis
Session Details
Jennifer Snyder
2016 (Montreal) Annual Meeting
Contributed Session
Provincial Centralized Research Ethics Boards: How a Canadian Clinical Trial Sponsor Supports the Quebec Model
Session Details
Alexander Demand
2016 (Montreal) Annual Meeting
Contributed Session
Publication Bias and Non-Reporting Found in Majority of Systematic Reviews and Meta-Analyses in Anesthesiology Journals
Session Details
Cole Wayant
2016 (Montreal) Annual Meeting
Contributed Session
Publication bias evaluations are not routinely conducted in clinical oncology systematic reviews
Session Details
Susan Kunselman
2016 (Montreal) Annual Meeting
Contributed Session
QUALITY ASSURANCE PROCESSES FOR PULMONARY FUNCTION TESTS IN AN ASTHMA CLINICAL TRIAL: THE ASTHMANET BARD TRIAL
Session Details
Tracey Serpi
2016 (Montreal) Annual Meeting
Contributed Session
Quality Studies: Using Risk Based Monitoring in the Department of Veterans Affairs Cooperative Studies Program to Enhance Human Subject Protection and Data Integrity
Session Details
Catherine Oldenburg
2016 (Montreal) Annual Meeting
Contributed Session
RANDOMIZED BY NATURE: CLINICAL TRIALS WITH THRESHOLD TREATMENT ASSIGNMENT
Session Details
Larisa Tereshchenko
2016 (Montreal) Annual Meeting
Contributed Session
Randomized Controlled Trial Adaptive CRT effect on ELectrical dysSYNChrony (aCRT ELSYNC): study design
Session Details
Pamela Shaw
2016 (Montreal) Annual Meeting
Session Proposal
Randomized controlled trials of behavior economics interventions: Examples and considerations for design
Session Details
Dave DeMets
2016 (Montreal) Annual Meeting
Contributed Session
Recommendations from the Clinical Trials Transformation Initiative Data Monitoring Committee Project
Session Details
David DeMets
2016 (Montreal) Annual Meeting
Session Proposal
Recommendations from the Clinical Trials Transformation Initiative Data Monitoring Committee Project
Session Details
Dena Howard
2016 (Montreal) Annual Meeting
Contributed Session
Recommendations on multiple-testing adjustment in multi-arm trials with correlated hypotheses
Session Details
Safawa Huq
2016 (Montreal) Annual Meeting
Contributed Session
Recruitment Strategies Implemented in the “B Cell Targeted Treatment in Myasthenia Gravis (BeatMG)” Trial: Understanding the Approach to Successful Recruitment for a Rare Disease Population Utilizing a Clinical Trial Network
Session Details
Aenne Glass
2016 (Montreal) Annual Meeting
Contributed Session
REDUCTION OF RADIATION EXPOSURE DURING ABLATION OF ATRIAL FIBRILLATION
Session Details
Marc Schwartz
2016 (Montreal) Annual Meeting
Contributed Session
Reproducible Research and Dynamically Generated Biostatistical Analyses
Session Details
Radhika Kondapaka
2016 (Montreal) Annual Meeting
Contributed Session
RESOLUTION OF ADVERSE EVENTS: DISCUSSION OF INNOVATIVE SOLUTIONS
Session Details
Katie Gillies
2016 (Montreal) Annual Meeting
Contributed Session
Retention in randomised trials: What matters to Trial Managers?
Session Details
Caroline Hurley
2016 (Montreal) Annual Meeting
Contributed Session
Risk assessment tools for clinical trial monitoring: a systematic review
Session Details
Amparo Casanova
2016 (Montreal) Annual Meeting
Contributed Session
SAMPLE SIZE CALCULATIONS FOR CLUSTER CROSSOVER RANDOMIZED TRIALS
Session Details
Brittany Schwefel
2016 (Montreal) Annual Meeting
Contributed Session
Sample Size Re-estimation of Event-Driven Trials with Composite Events and Delayed Data Ascertainment
Session Details
Laura Smeaton
2016 (Montreal) Annual Meeting
Contributed Session
SCREENING AND ENROLLMENT BY SEX IN HIV CLINICAL TRIALS – A CROSS-PROTOCOL ANALYSIS
Session Details
Lucille Sebastian
2016 (Montreal) Annual Meeting
Contributed Session
Screening logs – opportunities and cautions for central monitoring
Session Details
Gui-shuang Ying
2016 (Montreal) Annual Meeting
Contributed Session
SECONDARY ANALYSIS of CLINICAL TRIALS DATA – A BIOSTATISTICIAN’S EXPERIENCE
Session Details
Andres Tellez
2016 (Montreal) Annual Meeting
Contributed Session
Selective Withdrawal in an Open Label Clinical Trial: CRLX101 in Non-Small Cell Lung Cancer
Session Details
Hwasoon Kim
2016 (Montreal) Annual Meeting
Contributed Session
Simulation Study for Sample Size Re-Estimation Methods Based on Log-Rank Statistics for Non-Inferiority Studies with Censored Survival Data
Session Details
Dario Gregori
2016 (Montreal) Annual Meeting
Contributed Session
Some insights in setting non-inferiority margin when information is available on the trial arms effects
Session Details
Soeun Kim
2016 (Montreal) Annual Meeting
Contributed Session
Standardized Global Statistical Test for Combining Multiple Outcomes in Clinical Trials
Session Details
Zhibao Mi
2016 (Montreal) Annual Meeting
Contributed Session
Statistical Assessment and Adjustment of Imbalance Caused Biased Treatment Effect
Session Details
Rosemarie Mick
2016 (Montreal) Annual Meeting
Session Proposal
Statistical Challenges in Immuno-Oncology
Session Details
Emmanuel Sampene
2016 (Montreal) Annual Meeting
Contributed Session
Statistical Inference in Randomized Consent Designs in the Presence of Hawthorne Effects
Session Details
Anne Lindblad
2016 (Montreal) Annual Meeting
Contributed Session
STATISTICAL MONITORING IN CLINICAL TRIALS: AN EXPERIMENT TO DETECT FABRICATED DATA
Session Details
Ranran Dong
2016 (Montreal) Annual Meeting
Contributed Session
Stepped Wedge Cluster Randomized Controlled Trials with Two Layers of Clustering: Designs and Comparisons of Power
Session Details
Amber Randall
2016 (Montreal) Annual Meeting
Contributed Session
Strategic Considerations for CDISC Implementation
Session Details
Cindy Jacobson
2016 (Montreal) Annual Meeting
Contributed Session
STRATEGIES IMPLEMENTED FOR OPTIMIZED DISPENSING OF AN INVESTIGATIONAL NEW DRUG DELIVERY DEVICE IN A MULTI-SITE HIV PREVENTION CLINICAL TRIAL
Session Details
Lynda Constable
2016 (Montreal) Annual Meeting
Contributed Session
Strategies to improve recruitment in surgical trials: targeting patient and clinical preferences
Session Details
Briana Cameron
2016 (Montreal) Annual Meeting
Contributed Session
Stratification in the two-stage randomized trial design for testing treatment, self-selection, and treatment preference effects
Session Details
Pamela Tenaerts
2016 (Montreal) Annual Meeting
Session Proposal
Streamlining Clinical Trials: Putting Words into Action
Session Details
John Alexander
2016 (Montreal) Annual Meeting
Session Proposal
Streamlining clinical trials: the practicalities
Session Details
Susanna Jacobus
2016 (Montreal) Annual Meeting
Session Proposal
Strengthening the Oncology Cooperative Group Community-Based Clinical Research Enterprise
Session Details
Elizabeth Avery
2016 (Montreal) Annual Meeting
Contributed Session
STUDY AND DATA MANAGEMENT OF A CHURCH BASED CBPR INTERVENTION DEVELOPMENT PROJECT: LESSONS LEARNED
Session Details
Elias Klemperer
2016 (Montreal) Annual Meeting
Contributed Session
Study characteristics account for the majority of variance in clinical trials of medications for alcohol use disorders: A meta-analysis
Session Details
Nigel Scott
2016 (Montreal) Annual Meeting
Contributed Session
STUDY DRUG MANAGEMENT SYSTEM WITHIN AN INTERNATIONAL TRIALS CONSORTIUM
Session Details
Katelyn Garcia
2016 (Montreal) Annual Meeting
Contributed Session
SUSPENSION AND INTERVENTION MODIFICATION FOR PREGNANCIES IN A WEIGHT GAIN PREVENTION TRIAL: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL
Session Details
Shokoufeh Khalatbari
2016 (Montreal) Annual Meeting
Contributed Session
TATUM: A WEB-BASED TOOL FOR OBTAINING A TREATMENT ALLOCATION IN A RANDOMIZED CONTROLLED CLINICAL TRIAL WITH A BUILT IN TRACKING SYSTEM FOR THE MANAGEMENT OF THE RANDOMIZATION PROCESS
Session Details
Michaela Goodwin
2016 (Montreal) Annual Meeting
Contributed Session
Testing methods to increase response to questionnaires in a longitudinal study
Session Details
Luigia Scudeller
2016 (Montreal) Annual Meeting
Contributed Session
The BISON (Bloodstream Infections and Sepsis Outcomes measurement Network) initiative: systematic overview of outcomes used in systematic reviews on interventions for sepsis and/or bloodstream infections
Session Details
Valeria Musella
2016 (Montreal) Annual Meeting
Contributed Session
The challenge of electronic case report form in investigators-initiated studies
Session Details
Pamela Tenaerts, MD, MBA
2016 (Montreal) Annual Meeting
Contributed Session
The Clinical Trials Transformation Initiative: Improving the Quality and Efficiency of Clinical Trials
Session Details
Eve Jelstrom
2016 (Montreal) Annual Meeting
Contributed Session
THE CREATION, DEVELOPMENT AND USE OF AN ELECTRONIC SITE VISIT REPORT
Session Details
Ines Rombach
2016 (Montreal) Annual Meeting
Contributed Session
THE CURRENT PRACTICE OF HANDLING AND REPORTING MISSING OUTCOME DATA IN 8 WIDELY-USED PATIENT REPORTED OUTCOME MEASURES IN PUBLICATIONS OF RANDOMIZED CONTROLLED TRIALS: A REVIEW OF THE CURRENT LITERATURE
Session Details
Rebecca Elmore
2016 (Montreal) Annual Meeting
Contributed Session
THE ENVIRONMENTAL POLYMORPHISMS REGISTRY (EPR): A RESOURCE TO FACILITATE RECRUITMENT FOR CLINICAL STUDIES
Session Details
Cory Goldstein
2016 (Montreal) Annual Meeting
Contributed Session
THE ETHICS OF PRAGMATIC RANDOMIZED CONTROLLED TRIALS IN COMPARATIVE EFFECTIVENESS RESEARCH
Session Details
Simon Bacon
2016 (Montreal) Annual Meeting
Session Proposal
The International Behavioural Trials Network (IBTN): An International effort to improve the rigor and impact of behavioral clinical trials
Session Details
Norma Diaz-Mayoral
2016 (Montreal) Annual Meeting
Contributed Session
THE RELOCATION OF A SPECIMEN COLLECTION: COORDINATION OF LOGISTICS, SELECTING THE RIGHT PACKAGING, DATA MAPPING AND LESSONS LEARNED
Session Details
William Coar
2016 (Montreal) Annual Meeting
Contributed Session
The Right Time to Implement CDISC
Session Details
Rui (Sammi ) Tang
2016 (Montreal) Annual Meeting
Session Proposal
The Statistical Challenges in Recent Development of Personalized Medicine – through biomarker subgroup identification to companion diagnostic device development
Session Details
Karla Hemming
2016 (Montreal) Annual Meeting
Session Proposal
The stepped wedge cluster randomised trial – design and analysis and current challenges
Session Details
Navneet Hakhu
2016 (Montreal) Annual Meeting
Contributed Session
THE THREE PILLARS OF A SUCCESSFUL DATA MONITORING COMMITTEE ORGANIZATIONAL MEETING AND INTERIM MONITORING OF A RANDOMIZED CLINICAL TRIAL
Session Details
Kevin Wilson
2016 (Montreal) Annual Meeting
Contributed Session
The Use of Data Visualization Tools to Monitor Key Clinical Trial Activities
Session Details
Joseph Ross
2016 (Montreal) Annual Meeting
Contributed Session
The Yale Open Data Access (YODA) Project: Lessons Learned in Clinical Trial Data Sharing
Session Details
Shaun Treweek
2016 (Montreal) Annual Meeting
Contributed Session
Time well spent? A comparison of the work associated with collecting primary and secondary outcomes.
Session Details
Graham Quinn
2016 (Montreal) Annual Meeting
Contributed Session
Timely implementation of an ROP Telemedicine System
Session Details
Roger Lewis, MD, PhD
2016 (Montreal) Annual Meeting
Session Proposal
Training academic clinicians and biostatisticians to design and simulate adaptive clinical trials: the National Institutes of Neurological Disorders and Stroke Clinical Trials Methodology Advanced Course
Session Details
Wendy Parulekar
2016 (Montreal) Annual Meeting
Session Proposal
Translational scientists/ Bioinformaticians and Biostatisicians – Menage a Trois or Melange a Trois
Session Details
Natalie Blencowe
2016 (Montreal) Annual Meeting
Contributed Session
Uncovering the influence of performance bias: a methodological study nested within an RCT
Session Details
Wendy Parulekar
2016 (Montreal) Annual Meeting
Session Proposal
Use of administrative and registry data in clinical trials
Session Details
Dikla Blumberg
2016 (Montreal) Annual Meeting
Contributed Session
USE OF CERTIFICATES OF CONFIDENTIALITY TO PROTECT RESEARCH PARTICIPANTS’ PRIVACY IN RESPONSE TO LEGAL DEMANDS
Session Details
Ashley Case
2016 (Montreal) Annual Meeting
Contributed Session
Use of EDC Systems to Monitor Informed Contents Remotely
Session Details
Lisa A. Marsch, PhD and Carmen Rosa, MS
2016 (Montreal) Annual Meeting
Session Proposal
Use of Mobile Health Technologies in Pragmatic Clinical Trials
Session Details
Paul VanVeldhuisen, PhD
2016 (Montreal) Annual Meeting
Session Proposal
Using “BIG” Health Care Clinical Data to Conduct Clinical Research
Session Details
Stephanie DuBose
2016 (Montreal) Annual Meeting
Contributed Session
USING A PATIENT REGISTRY TO CONDUCT NON-CLINIC ENGAGED STUDIES
Session Details
Scott Evans
2016 (Montreal) Annual Meeting
Contributed Session
USING ENDPOINTS TO ANALYZE PATIENTS RATHER THAN PATIENTS TO ANALYZE ENDPOINTS: A PRE-TRIAL SUBSTUDY TO DEVELOP A GLOBAL OUTCOME FOR CLINICAL TRIALS
Session Details
Matthias Pierce
2016 (Montreal) Annual Meeting
Contributed Session
Using trials to identify personalised treatment rules
Session Details
Thuong La
2016 (Montreal) Annual Meeting
Contributed Session
Utilizing cloud-based file synchronization platform for real-time data transfer, central storage and collaboration network
Session Details
Kirsty Loudon
2016 (Montreal) Annual Meeting
Contributed Session
Validity and Reliability of PRECIS-2 – a tool designed to help trialists match their trial design decisions to the needs of those they hope will use the results
Session Details
Lucille Sebastian
2016 (Montreal) Annual Meeting
Contributed Session
Variation in routine follow up for preterm babies: implications for clinical trials
Session Details
Loretta Davies
2016 (Montreal) Annual Meeting
Contributed Session
WHAT CAN WE LEARN FROM EXPERIENCE? IMPACT OF HEALTHCARE PROVIDER EFFECTS IN THE TOTAL OR PARTIAL KNEE ARTHROPLASTY TRIAL (TOPKAT)
Session Details
TBC
2016 (Montreal) Annual Meeting
Session Proposal
What happens when a trial is interrupted? How to deal with suspension of randomisation and restart your trial
Session Details
Kerry Avery
2016 (Montreal) Annual Meeting
Contributed Session
What is the effect of item order (patient reported outcomes first or last?) in a questionnaire on the measurement and prioritisation of outcomes: a randomised controlled trial
Session Details
Todd MacKenzie
2016 (Montreal) Annual Meeting
Contributed Session
Who Are the Compliers? Reporting Baseline Characteristics to Accompany the Causal Effect of Treatment
Session Details